Cover Image

Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy

This study investigated the potential of immune checkpoint inhibitors (ICIs) combined with chemotherapy as a promising treatment approach for malignancies. This report focuses on a patient with drug-induced liver injury (DILI) following the administration of chemotherapy and ICIs. A 63-year-old pati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shike Lou (Author), Xiaoyin Wang (Author), Fei Yuan (Author), Gangde Zhao (Author), Mingyang Feng (Author), Yezhou Ding (Author), Lanyi Lin (Author), Kehui Liu (Author), Xiaolin Wang (Author), Wanqing Chi (Author), Hui Wang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB
by: Shike Lou, et al.
Published: (2023)

Trends and socioeconomic factors in smoking and alcohol consumption among Chinese people: evidence from the 2008-2018 National Health Service Surveys in Jiangsu Province
by: Kehui Liu, et al.
Published: (2021)

Immune Checkpoint Inhibitor-Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
by: Li Wang, et al.
Published: (2021)

Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC
by: Zhang Tao, et al.
Published: (2022)

Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
by: Xiangxing Liu, et al.
Published: (2022)

Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?
by: Tang-Her Jaing, et al.
Published: (2024)

Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management
by: Haiyang Wang, et al.
Published: (2019)

Local delivery of checkpoints antibodies
by: Chao Wang, et al.
Published: (2017)

Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis
by: Jingyang Su, et al.
Published: (2024)

Chemotherapy and Immune Checkpoint Inhibitors in a Case of SMARCA4-dUT: A Case Report and Review of Literature
by: Akriti Pokhrel MD, et al.
Published: (2023)

An Error Analysis of Students' Difficulties in Differential Calculus
by: Meiliasari Meiliasari, et al.
Published: (2021)

Difficulties in differential diagnosis of atopic dermatitis in children
by: L.V. Besh, et al.
Published: (2018)

The Difficulties of Differential Diagnosis of the Bronchial Obstruction Syndrome
by: I. V. Demko, et al.
Published: (2021)

Difficulties in the differential diagnosis of tumors in the female reproductive system
by: Ju. V. Nosova, et al.
Published: (2020)

Difficulties of Differential Diagnosis of Colon Diseases in the Infectious Practice
by: L. N. Mazankova, et al.
Published: (2016)

DIFFICULTIES IN THE DIFFERENTIAL DIAGNOSIS OF HEMOLYTIC UREMIC SYNDROME IN CHILDREN
by: L. A. Lityaeva, et al.
Published: (2015)

Difficulties in the differential diagnosis of myelodysplastic syndrome and acute leukemia
by: Alina V. Maltseva, et al.
Published: (2023)

Clinical case of Gradenigo syndrome, difficulties of differential diagnosis
by: Elena S. Ananyeva, et al.
Published: (2023)

Difficulties in the differential diagnosis of granulomatosis with polyangiitis and scarring pemphigoid
by: N. A. Magdeeva, et al.
Published: (2020)

Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy
by: Yongrong Yao, et al.
Published: (2022)

The moderation of satisfaction with working conditions in the association between workload and mental health among healthcare workers collecting test samples in the post-COVID-19 era
by: Kehui Wang, et al.
Published: (2023)

Differential Effect of Schisandrin B Stereoisomers on ATR-Mediated DNA Damage Checkpoint Signaling
by: Naoto Tatewaki, et al.
Published: (2013)

Mortality pattern trends and disparities among Chinese from 2004 to 2016
by: Jicun Zhu, et al.
Published: (2019)

FTO protects human granulosa cells from chemotherapy-induced cytotoxicity
by: Rongli Wang, et al.
Published: (2022)

Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023)

The built environment impacts on route choice from home to school for rural students: A stated preference experiment
by: Li Han, et al.
Published: (2022)

Difficulties in differential diagnosis tuberculosis and Crohn's disease. Case report
by: Oleg V. Knyazev, et al.
Published: (2022)

Difficulties of differential diagnosis of lymphadenopathy in acute brucellosis (clinical cases)
by: Nikita A. Tereshkin, et al.
Published: (2023)

Detecting performance difficulty of learners in colonoscopy: Evidence from eye-tracking
by: Xin Liu, et al.
Published: (2021)

The Signaling Pathway of PGE2 and Its Regulatory Role in T Cell Differentiation
by: Yang An, et al.
Published: (2021)

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
by: Maria Maddalena Nicoletti, et al.
Published: (2023)

Checkpoint Inhibitor Induced Acute Liver Failure
by: Chukwunonso Ezeani MD, et al.
Published: (2024)

Psoriasis de novo or exacerbation by PD-1 checkpoint inhibitors
by: Zi Wan, et al.
Published: (2024)

Risk Factors and Prognostic Analysis of Immune Checkpoint Inhibitor-Related Colitis in Lung Cancer
by: Wang S, et al.
Published: (2024)

Nanoalbumin-prodrug conjugates prepared via a thiolation‐and‐conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8+ T‐cell infiltration
by: Long Chen, et al.
Published: (2023)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
by: Chenxin Chen, et al.
Published: (2021)

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer
by: Mengjie Wang, et al.
Published: (2022)

Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high‐grade transformation from differentiated thyroid carcinoma
by: Haiyan Gu, et al.
Published: (2024)

Patients with advanced cancer were treated with immune checkpoint inhibitors and injected with COVID-19 vaccine to improve their prognosis without increasing pancreatic related adverse events
by: Min Li, et al.
Published: (2024)

Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study
by: Jiaxin Wang, et al.
Published: (2024)